Acupuncture in chemotherapy-induced dysgeusia (AcuDysg): study protocol of a randomised controlled trial.

Publikation

Acupuncture in chemotherapy-induced dysgeusia (AcuDysg): study protocol of a randomised controlled trial.

Wissenschaftlicher Artikel/Review - 10.03.2023

Huber Christine, Zhang Linxin, Schlaeppi Marc, Müller Twyla, Roll Stephanie, Voiss Petra, Barth Jürgen, Driessen Christoph, Witt Claudia M

Zitation

Huber C, Zhang L, Schlaeppi M, Müller T, Roll S, Voiss P, Barth J, Driessen C, Witt C. Acupuncture in chemotherapy-induced dysgeusia (AcuDysg): study protocol of a randomised controlled trial. BMJ Open 2023; 13:e066137.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

BMJ Open 2023; 13

Veröffentlichungsdatum

10.03.2023

eISSN (Online)

2044-6055

Seiten

e066137

Kurzbeschreibung/Zielsetzung

Dysgeusia is a common side effect of chemotherapy in patients with cancer, but to date, there is no effective treatment. Many patients with cancer request complementary medicine treatment in addition to their cancer treatments, and acupuncture is highly accepted for patients with cancer; however, evidence regarding the effectiveness of acupuncture for dysgeusia is scarce.The study investigates the effectiveness of an additional dysgeusia-specific acupuncture plus self-acupressure intervention compared with supportive acupuncture plus self-acupressure intervention alone for chemotherapy-induced dysgeusia in patients with cancer.